PrimeVigilance, an Ergomed company is pleased to announce and welcome the appointment of Dr. Olaolu Imasogie as Chief Medical Officer, with immediate effect.

Dr. Imasogie’s last position was Senior Vice President, Medical Affairs, Pharmacovigilance & Medical Information of Iroko Pharmaceuticals. Dr Imasogie joins us with more than 12 years of experience in Pharmacovigilance and Medical Information management and Senior leadership.

In addition, Dr Imasogie is qualified in clinical medicine, Microsoft Certified Systems engineering, continuous medical education, public health and pharmaceutical sales.

“I am very pleased that Dr. Imasogie has decided to join our company, bringing with him his unique expertise making him a valuable asset to the company growth ” commented Dr. Jan Petracek, CEO of PrimeVigilance.

If you would like to know more about our global drug safety services and how we can help, please contact us at




This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

For perfomance reasons we use Cloudflare as a CDN network. This saves a cookie "__cfduid" to apply security settings on a per-client basis. This cookie is strictly necessary for Cloudflare's security features and cannot be turned off.
  • __cfduid

Decline all Services
Accept all Services